Dyslipidemia has been globally recognized, for almost seven decades, as one of the most important risk factors for the development and complications of atherosclerotic cardiovascular disease (ASCVD) [...].
Fras Z., Jug B., Penson P.E., Rizzo M. (2021). Challenges and opportunities on lipid metabolism disorders diagnosis and therapy: Novel insights and future perspective. METABOLITES, 11(9) [10.3390/metabo11090611].
Challenges and opportunities on lipid metabolism disorders diagnosis and therapy: Novel insights and future perspective
Rizzo M.
2021-01-01
Abstract
Dyslipidemia has been globally recognized, for almost seven decades, as one of the most important risk factors for the development and complications of atherosclerotic cardiovascular disease (ASCVD) [...].
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
metabolites-11-00611.pdf
accesso aperto
Tipologia:
Versione Editoriale
Dimensione
171 kB
Formato
Adobe PDF
|
171 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
